pharmaphorum
banner
pharmaphorum.bsky.social
pharmaphorum
@pharmaphorum.bsky.social
94 followers 480 following 900 posts
pharmaphorum.com, and its magazine Deep Dive, is a leading online destination for pharmaceutical industry and healthcare news, insight, and debate
Posts Media Videos Starter Packs
#Ipsen has agreed to buy ImCheck and its anti-BTN3A antibody for acute myeloid leukaemia in a deal that could be worth up to €1bn.

pharmaphorum.com/news/ipsen-b...
GSK and Spero's cabapenem tebipenem is the first oral antibiotic in the class to show efficacy in complicated urinary tract infections.

pharmaphorum.com/news/gsk-wil...
Has #Roche taken a lead in the oral SERD category of breast cancer therapies with data showing activity in wild-type ESR1 patients?

pharmaphorum.com/news/esmo-cl...
#EliLilly's CDK4/6 inhibitor #Verzenio reduced the risk of death by 15.8% when used as adjuvant treatment for early-stage HR-positive, HER2-negative #breastcancer, according the reveal of data from the #monarchEtrial.

pharmaphorum.com/news/esmo-li...
Researchers have evidence that a sample of menstrual blood could allow a diagnosis of #endometriosis within weeks, rather than years, and guide new drug development.
pharmaphorum.com/news/could-e...
Could endometriosis be diagnosed with a simple test?
pharmaphorum.com
AI-powered autonomous lab firm Lila Sciences upsizes its Series A to $350m, heading a bumper week for new biotech financings.

pharmaphorum.com/news/lila-sc...
The #FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher programme.

pharmaphorum.com/news/fda-han...